HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 261.9% based on the discounted cash flow analysis.
| Market cap | $6.14 Billion |
|---|---|
| Enterprise Value | $7.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.41 |
| Outstanding Shares | 231,746,126 |
| P/E Ratio | -45.1 |
|---|---|
| PEG | 14.88 |
| Price to Sales | 2.5 |
| Price to Book Ratio | 27.51 |
| Enterprise Value to Revenue | 2.8 |
| Enterprise Value to EBIT | -91.88 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7482▼ 4.50% |
|---|---|
| Total Calls | 36,999,234▲ 3.11% |
| Total Puts | 27,684,034▼ 2.74% |
Holdings and activity of institutional investors.
| Ownership % | 71.68%▲ 6.27% |
|---|---|
| Total Invested | $5.70B▲ 84.09% |
| Investors Holding | 586▲ 96.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...